Lineage Cell Therapeutics
LCTX
#8223
Rank
A$0.23 B
Marketcap
$1.27
Share price
1.22%
Change (1 day)
-36.48%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$53.2 M

According to Lineage Cell Therapeutics 's latest financial reports the company's total liabilities are A$53.2 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lineage Cell Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$57.23 M-24.7%
2022-12-31A$76.01 M-34.12%
2021-12-31A$0.11 B591.92%
2020-12-31A$16.67 M-17.96%
2019-12-31A$20.32 M52.1%
2018-12-31A$13.36 M16.2%
2017-12-31A$11.49 M-31.29%
2016-12-31A$16.73 M-33.06%
2015-12-31A$25 M68.01%
2014-12-31A$14.88 M-14.19%
2013-12-31A$17.34 M230.39%
2012-12-31A$5.24 M23.1%
2011-12-31A$4.26 M12.57%
2010-12-31A$3.78 M42.58%
2009-12-31A$2.65 M-65.18%
2008-12-31A$7.62 M107.04%
2007-12-31A$3.68 M15.46%
2006-12-31A$3.19 M8.34%
2005-12-31A$2.94 M93.7%
2004-12-31A$1.52 M-67.72%
2003-12-31A$4.71 M-0.48%
2002-12-31A$4.73 M18.41%
2001-12-31A$3.99 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$39.25 M-26.22%๐Ÿ‡บ๐Ÿ‡ธ USA